Bruges M, Barata J D, Oliveira C, Furstenau C, Gomes E M, Simões J
Serviço de Nefrologia, Hospital de Santa Cruz, Carnaxide.
Acta Med Port. 1994 Mar;7(3):165-70.
The use of bicarbonate buffer in dialysis is more physiological than acetate. The aim of this prospective study was to compare the hemodynamic stability, acid-base and electrolyte balance changes in a group of 5 hospital hemodialysis (HD) patients, with 3 different dialysis fluids: one with 30 mEq/l of bicarbonate (B30), another with 34 mEq/l of bicarbonate (B34) and the last with acetate (ACE). All the patients had more than 12 months in HD. Each patient had HD treatment with one of the 3 different dialysis fluids: ACE, B30, B34. Each HD had a duration of 4 hours, with less than 5% dry weight ultrafiltration (UF) and continuous cardiac monitoring. The following clinical and laboratory data were evaluated: arterial blood pressure (BP), cardiac rate (CR), respiratory rate (RR), cardiac arrhythmias, blood urea, creatinine, sodium, potassium, magnesium, total calcium (Ca), ionised calcium (Ca++), pH, bicarbonate (HCO3-) and pCO2. Statistic analysis was performed using Student's paired t test and ANOVA with Bonferroni correction. Clinical evaluation showed a CR increase only in the ACE group (pre X = 78.4 to 4 degrees h X = 102.6 p < 0.001). Analytical results demonstrated, at the 1st h, Ca++ stability in the B30 group; in the first 30' the pH decreased in the ACE group (pre X = 7.35 to 30' X = 7.34); during HD, HCO3- was not corrected in the ACE group (pre X = 19.4 to 4th h X = 20.0); at 4th, pCO2 also decreased in this group (pre X = 34.5 to 4th h X = 28.4 p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
在透析中使用碳酸氢盐缓冲液比使用醋酸盐更符合生理状态。这项前瞻性研究的目的是比较一组5名医院血液透析(HD)患者在使用三种不同透析液时的血流动力学稳定性、酸碱和电解质平衡变化:一种含有30 mEq/l碳酸氢盐(B30),另一种含有34 mEq/l碳酸氢盐(B34),最后一种含有醋酸盐(ACE)。所有患者均接受血液透析超过12个月。每位患者使用三种不同透析液之一进行HD治疗:ACE、B30、B34。每次HD持续4小时,超滤(UF)量低于干体重的5%,并进行连续心脏监测。评估了以下临床和实验室数据:动脉血压(BP)、心率(CR)、呼吸频率(RR)、心律失常、血尿素、肌酐、钠、钾、镁、总钙(Ca)、离子钙(Ca++)、pH、碳酸氢盐(HCO3-)和pCO2。使用学生配对t检验和带有Bonferroni校正的方差分析进行统计分析。临床评估显示,仅ACE组心率增加(治疗前X = 78.4至4小时X = 102.6,p < 0.001)。分析结果表明,第1小时,B30组Ca++稳定;前30分钟,ACE组pH下降(治疗前X = 7.35至30分钟X = 7.34);HD期间,ACE组HCO3-未得到纠正(治疗前X = 19.4至第4小时X = 20.0);第4小时,该组pCO2也下降(治疗前X = 34.5至第4小时X = 28.4,p < 0.05)。(摘要截断于250字)